Medanta-The Medicity

Gurgaon 122018

2 studies enrolling now · 9 studies all time

What they study most

Atrial Fibrillation, Heart Failure, Heart Failure With Left Bundle Branch Block, Implantable Defibrillator, Myelodysplastic Syndromes, Percutaneous Coronary Intervention, Rheumatoid Arthritis, Tachyarrhythmias, Ventricular Dysfunction

Studies at this site

• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• AdaptResponse Clinical Trial — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed
• Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access — Completed